wegovy.com

{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.wegovy.com/",
"name": "Weight Management for Adults with Obesity | Wegovy® (semaglutide)",
"headline": "Weight Management for Adults with Obesity | Wegovy® (semaglutide)",
"description": "Learn about Wegovy® (semaglutide) injection  2.4 mg, 7.2 mg or tablets 25 mg for adults with obesity or overweight and see how it supports weight loss with guidance, dosing information, and savings resources to help you get started.  Read important safety and prescribing info, including boxed warning.",
"audience": {
  "@type": "MedicalAudience",
  "audienceType": "Patients"
},
"specialty": {
  "@type": "MedicalSpecialty",
  "name": "Endocrine"
},
"mainEntity": {
  "@type": "Drug",
  "name": "Wegovy®",
  "nonProprietaryName": "semaglutide",
  "activeIngredient": "semaglutide",
  "alternateName": [
    "Wegovy® (semaglutide) injection",
    "Wegovy® (semaglutide) tablets"
  ],
  "dosageForm": [
    "injection",
    "tablet"
  ],
  "administrationRoute": [
    "subcutaneous",
    "oral"
  ],
  "prescriptionStatus": "https://schema.org/PrescriptionOnly",
  "prescribingInfo": "https://www.novo-pi.com/wegovy.pdf",
  "drugClass": "GLP-1 receptor agonist",
  "pregnancyWarning": "Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk.",
  "warning": "Wegovy® may cause serious side effects, including: Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).",
  "doseSchedule": [
    {
      "@type": "DoseSchedule",
      "doseUnit": "mg",
      "doseValue": "2.4",
      "frequency": "once-weekly",
      "targetPopulation": "adults with obesity or overweight with weight-related medical problems"
    },
    {
      "@type": "DoseSchedule",
      "doseUnit": "mg",
      "doseValue": "7.2",
      "frequency": "once-weekly",
      "targetPopulation": "adults who may need a higher dose"
    },
    {
      "@type": "DoseSchedule",
      "doseUnit": "mg",
      "doseValue": "25",
      "frequency": "once-daily",
      "targetPopulation": "adults with obesity or overweight"
    }
  ],
  "image": {
    "@type": "ImageObject",
    "name": "Once-weekly Wegovy® semaglutide tablets 25 mg semaglutide injection 2.4 milligrams logo",
    "contentUrl": "https://s7d9.scene7.com/is/image/novonordisk/wegovy-logo-nav"
  },
  "manufacturer": {
    "@type": "Organization",
    "name": "Novo Nordisk",
    "url": "https://www.novonordisk-us.com/home.html",
    "logo": "https://s7d9.scene7.com/is/image/novonordisk/nn_logo-1",
    "address": {
      "@type": "PostalAddress",
      "streetAddress": "800 Scudders Mill Road",
      "addressLocality": "Plainsboro",
      "addressRegion": "NJ",
      "postalCode": "08536",
      "addressCountry": "US"
    }
  }
},
"about": [
  {
    "@type": "MedicalCondition",
    "name": "obesity",
    "alternateName": [
      "overweight",
      "excess weight"
    ]
  },
  {
    "@type": "MedicalCondition",
    "name": "cardiovascular disease",
    "alternateName": [
      "heart disease",
      "major cardiovascular events"
    ]
  },
  {
    "@type": "MedicalTherapy",
    "guideline": [
      "Wegovy® (semaglutide) injection and Wegovy® (semaglutide) tablets are prescription medicines used with a reduced calorie diet and increased physical activity to: reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight. help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off."
    ],
    "adverseOutcome": [
      "The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, changes in skin sensations, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and hair loss."
    ],
    "contraindication": [
      "you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)",
      "you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets"
    ]
  }
],
"breadcrumb": {
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position": 1,
      "item": {
        "@id": "https://www.wegovy.com/",
        "name": "Home"
      }
    }
  ]
},
"mainContentOfPage": [
  {
    "@type": "WebPageElement",
    "headline": "Meet Wegovy® Pill",
    "text": "Wegovy® is the first and only FDA-approved semaglutide pill for weight loss.",
    "potentialAction": {
      "@type": "Action",
      "name": "Results With the Pill",
      "target": "https://www.wegovy.com/obesity/is-wegovy-right-for-me/wegovy-pill-results.html"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "For adults with obesity, along with diet and exercise, lose weight and keep it off. Live lighter with less weight versus before starting Wegovy"
  },
  {
    "@type": "WebPageElement",
    "headline": "Wegovy® gives you options."
  },
  {
    "@type": "WebPageElement",
    "headline": "Meet Wegovy® HD",
    "text": "Wegovy® HD (semaglutide) is a new, higher dose for those who may need it.",
    "potentialAction": {
      "@type": "Action",
      "name": "Results With Wegovy® HD",
      "target": "https://www.wegovy.com/obesity/is-wegovy-right-for-me/wegovy-pen-results.html"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "Have Wegovy® and ready to start?",
    "potentialAction": {
      "@type": "Action",
      "name": "Start Wegovy®",
      "target": "https://www.wegovy.com/obesity/starting-wegovy/getting-started-on-wegovy.html"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "Wegovy® goes beyond weight management for adults"
  },
  {
    "@type": "WebPageElement",
    "headline": "Wegovy® may help reduce the risk of major heart events",
    "text": "For adults with known heart disease with obesity or overweight, along with diet and increased physical activity. Wegovy® may lower your risk of major cardiovascular events, such as death, heart attack, or stroke.",
    "potentialAction": {
      "@type": "Action",
      "name": "Adults With Heart Disease",
      "target": "https://heart.wegovy.com/"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "Support your adolescent's weight-management goals",
    "text": "For children aged 12 and up with obesity, along with a reduced-calorie diet and increased physical activity, to lose weight and keep it off. Wegovy® pill is not approved for adolescents with obesity.",
    "potentialAction": {
      "@type": "Action",
      "name": "Wegovy® Pen for Adolescents",
      "target": "https://adolescents.wegovy.com"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "Talk to your healthcare professional",
    "text": "Only a healthcare professional can determine whether Wegovy® (semaglutide) is the appropriate option for you.",
    "potentialAction": {
      "@type": "Action",
      "name": "Take the First Step",
      "target": "https://www.wegovy.com/obesity/how-to-get-wegovy.html"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "Join the millions of people who've been prescribed Wegovy®*",
    "text": "*This is based on information licensed from IQVIA: LAAD, for period June 2021-December 2025, reflecting estimates of real-world activity. All rights reserved.",
    "potentialAction": {
      "@type": "Action",
      "name": "Is It Right for Me?",
      "target": "https://www.wegovy.com/obesity/is-wegovy-right-for-me.html"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "Get Wegovy® with or without insurance",
    "text": "There are ways to save on the cost of Wegovy®, even if you don't have insurance.",
    "potentialAction": {
      "@type": "Action",
      "name": "Find Out How",
      "target": "https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html"
    }
  },
  {
    "@type": "WebPageElement",
    "headline": "Become a WEGOVY® INSIDER",
    "text": "Be the first to know about all things Wegovy®. Whether it's info on weight-loss results, savings offers, or lifestyle tips—we've got it all. Sign up now to get the latest news.",
    "potentialAction": {
      "@type": "Action",
      "name": "Sign Up Now",
      "target": "https://www.wegovy.com/obesity/wegovy-insider.html"
    }
  }
]
}